ペット用がん治療の世界市場 2020年:メーカー別、地域別、種類・用途別

• 英文タイトル:Global Pet Cancer Therapeutics Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

Global Pet Cancer Therapeutics Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025「ペット用がん治療の世界市場 2020年:メーカー別、地域別、種類・用途別」(市場規模、市場予測)調査レポートです。• レポートコード:D005-12013
• 出版社/出版日:GlobalInfoResearch / 2020年5月
• レポート形態:英文、PDF、102ページ
• 納品方法:Eメール(納期2~3日)
• 産業分類:医療・製薬
• 販売価格(消費税別)
  Single User¥361,920 (USD3,480)▷ お問い合わせ
  Multi User¥542,880 (USD5,220)▷ お問い合わせ
  Corporate User¥723,840 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、ペット用がん治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。ペット用がん治療の種類別市場規模(化学療法、標的療法、併用療法、免疫療法)、用途別市場規模(リンパ腫、肥満細胞がん、黒色腫、乳腺、扁平上皮がん、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(販売量、市場シェア、製品概要、SWOT分析):Aratana Therapeutics, Inc、Rhizen Pharmaceutical SA、Zenoaq、AB Science、Karyopharm Therapeutics, Inc、Boehringer Ingelheim International GmbH、Oasmia Pharmaceuticals AB、VetDC, Inc、Morphogenesis, Inc、Regeneus Ltd.、Zoetis
・地域別グローバル市場分析 2015年-2020年
・ペット用がん治療の北米市場(アメリカ、カナダ、メキシコ)
・ペット用がん治療のヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・ペット用がん治療のアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・ペット用がん治療の南米市場(ブラジル、アルゼンチン)
・ペット用がん治療の中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:化学療法、標的療法、併用療法、免疫療法
・用途別分析:リンパ腫、肥満細胞がん、黒色腫、乳腺、扁平上皮がん、その他
・地域別市場規模予測 2021年-2025年
・販売チャネル、流通業者、代理店
・調査の結果・結論

Market Overview
The global Pet Cancer Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.9% in the forecast period of 2020 to 2025 and will expected to reach USD 206.2 million by 2025, from USD 164.2 million in 2019.

The Pet Cancer Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Pet Cancer Therapeutics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Pet Cancer Therapeutics market has been segmented into
Chemotherapy
Targeted Therapy
Combination Therapy
Immunotherapy

By Application, Pet Cancer Therapeutics has been segmented into:
Lymphoma
Mast Cell Cancer
Melanoma
Mammary
Squamous Cell Cancer
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Pet Cancer Therapeutics market presented in the report. This section sheds light on the sales growth of different regional and country-level Pet Cancer Therapeutics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Pet Cancer Therapeutics market.

The report offers in-depth assessment of the growth and other aspects of the Pet Cancer Therapeutics market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Pet Cancer Therapeutics Market Share Analysis
Pet Cancer Therapeutics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Pet Cancer Therapeutics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Pet Cancer Therapeutics sales, revenue and market share for each player covered in this report.

The major players covered in Pet Cancer Therapeutics are:
Aratana Therapeutics, Inc
Rhizen Pharmaceutical SA
Zenoaq
AB Science
Karyopharm Therapeutics, Inc
Boehringer Ingelheim International GmbH
Oasmia Pharmaceuticals AB
VetDC, Inc
Morphogenesis, Inc
Regeneus Ltd.
Zoetis

Among other players domestic and global, Pet Cancer Therapeutics market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pet Cancer Therapeutics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Pet Cancer Therapeutics, with price, sales, revenue and global market share of Pet Cancer Therapeutics in 2018 and 2019.
Chapter 3, the Pet Cancer Therapeutics competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pet Cancer Therapeutics breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Pet Cancer Therapeutics market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Pet Cancer Therapeutics sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

Table of Contents

1 Market Overview
1.1 Pet Cancer Therapeutics Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Pet Cancer Therapeutics Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Chemotherapy
1.2.3 Targeted Therapy
1.2.4 Combination Therapy
1.2.5 Immunotherapy
1.3 Market Analysis by Application
1.3.1 Overview: Global Pet Cancer Therapeutics Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Lymphoma
1.3.3 Mast Cell Cancer
1.3.4 Melanoma
1.3.5 Mammary
1.3.6 Squamous Cell Cancer
1.3.7 Others
1.4 Overview of Global Pet Cancer Therapeutics Market
1.4.1 Global Pet Cancer Therapeutics Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Aratana Therapeutics, Inc
2.1.1 Aratana Therapeutics, Inc Details
2.1.2 Aratana Therapeutics, Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Aratana Therapeutics, Inc SWOT Analysis
2.1.4 Aratana Therapeutics, Inc Product and Services
2.1.5 Aratana Therapeutics, Inc Pet Cancer Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Rhizen Pharmaceutical SA
2.2.1 Rhizen Pharmaceutical SA Details
2.2.2 Rhizen Pharmaceutical SA Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Rhizen Pharmaceutical SA SWOT Analysis
2.2.4 Rhizen Pharmaceutical SA Product and Services
2.2.5 Rhizen Pharmaceutical SA Pet Cancer Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Zenoaq
2.3.1 Zenoaq Details
2.3.2 Zenoaq Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Zenoaq SWOT Analysis
2.3.4 Zenoaq Product and Services
2.3.5 Zenoaq Pet Cancer Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 AB Science
2.4.1 AB Science Details
2.4.2 AB Science Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 AB Science SWOT Analysis
2.4.4 AB Science Product and Services
2.4.5 AB Science Pet Cancer Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Karyopharm Therapeutics, Inc
2.5.1 Karyopharm Therapeutics, Inc Details
2.5.2 Karyopharm Therapeutics, Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Karyopharm Therapeutics, Inc SWOT Analysis
2.5.4 Karyopharm Therapeutics, Inc Product and Services
2.5.5 Karyopharm Therapeutics, Inc Pet Cancer Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Boehringer Ingelheim International GmbH
2.6.1 Boehringer Ingelheim International GmbH Details
2.6.2 Boehringer Ingelheim International GmbH Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Boehringer Ingelheim International GmbH SWOT Analysis
2.6.4 Boehringer Ingelheim International GmbH Product and Services
2.6.5 Boehringer Ingelheim International GmbH Pet Cancer Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Oasmia Pharmaceuticals AB
2.7.1 Oasmia Pharmaceuticals AB Details
2.7.2 Oasmia Pharmaceuticals AB Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Oasmia Pharmaceuticals AB SWOT Analysis
2.7.4 Oasmia Pharmaceuticals AB Product and Services
2.7.5 Oasmia Pharmaceuticals AB Pet Cancer Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 VetDC, Inc
2.8.1 VetDC, Inc Details
2.8.2 VetDC, Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 VetDC, Inc SWOT Analysis
2.8.4 VetDC, Inc Product and Services
2.8.5 VetDC, Inc Pet Cancer Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Morphogenesis, Inc
2.9.1 Morphogenesis, Inc Details
2.9.2 Morphogenesis, Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Morphogenesis, Inc SWOT Analysis
2.9.4 Morphogenesis, Inc Product and Services
2.9.5 Morphogenesis, Inc Pet Cancer Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Regeneus Ltd.
2.10.1 Regeneus Ltd. Details
2.10.2 Regeneus Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Regeneus Ltd. SWOT Analysis
2.10.4 Regeneus Ltd. Product and Services
2.10.5 Regeneus Ltd. Pet Cancer Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Zoetis
2.11.1 Zoetis Details
2.11.2 Zoetis Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Zoetis SWOT Analysis
2.11.4 Zoetis Product and Services
2.11.5 Zoetis Pet Cancer Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Pet Cancer Therapeutics Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Pet Cancer Therapeutics Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Pet Cancer Therapeutics Manufacturer Market Share in 2019
3.3.2 Top 6 Pet Cancer Therapeutics Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Pet Cancer Therapeutics Sales, Revenue and Market Share by Regions
4.1.1 Global Pet Cancer Therapeutics Sales and Market Share by Regions (2015-2020)
4.1.2 Global Pet Cancer Therapeutics Revenue and Market Share by Regions (2015-2020)
4.2 North America Pet Cancer Therapeutics Sales and Growth Rate (2015-2020)
4.3 Europe Pet Cancer Therapeutics Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Pet Cancer Therapeutics Sales and Growth Rate (2015-2020)
4.5 South America Pet Cancer Therapeutics Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Pet Cancer Therapeutics Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Pet Cancer Therapeutics Sales, Revenue and Market Share by Country
5.1.1 North America Pet Cancer Therapeutics Sales and Market Share by Country (2015-2020)
5.1.2 North America Pet Cancer Therapeutics Revenue and Market Share by Country (2015-2020)
5.2 United States Pet Cancer Therapeutics Sales and Growth Rate (2015-2020)
5.3 Canada Pet Cancer Therapeutics Sales and Growth Rate (2015-2020)
5.4 Mexico Pet Cancer Therapeutics Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Pet Cancer Therapeutics Sales, Revenue and Market Share by Country
6.1.1 Europe Pet Cancer Therapeutics Sales and Market Share by Country (2015-2020)
6.1.2 Europe Pet Cancer Therapeutics Revenue and Market Share by Country (2015-2020)
6.2 Germany Pet Cancer Therapeutics Sales and Growth Rate (2015-2020)
6.3 UK Pet Cancer Therapeutics Sales and Growth Rate (2015-2020)
6.4 France Pet Cancer Therapeutics Sales and Growth Rate (2015-2020)
6.5 Russia Pet Cancer Therapeutics Sales and Growth Rate (2015-2020)
6.6 Italy Pet Cancer Therapeutics Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Pet Cancer Therapeutics Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Pet Cancer Therapeutics Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Pet Cancer Therapeutics Revenue and Market Share by Regions (2015-2020)
7.2 China Pet Cancer Therapeutics Sales and Growth Rate (2015-2020)
7.3 Japan Pet Cancer Therapeutics Sales and Growth Rate (2015-2020)
7.4 Korea Pet Cancer Therapeutics Sales and Growth Rate (2015-2020)
7.5 India Pet Cancer Therapeutics Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Pet Cancer Therapeutics Sales and Growth Rate (2015-2020)
7.7 Australia Pet Cancer Therapeutics Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Pet Cancer Therapeutics Sales, Revenue and Market Share by Country
8.1.1 South America Pet Cancer Therapeutics Sales and Market Share by Country (2015-2020)
8.1.2 South America Pet Cancer Therapeutics Revenue and Market Share by Country (2015-2020)
8.2 Brazil Pet Cancer Therapeutics Sales and Growth Rate (2015-2020)
8.3 Argentina Pet Cancer Therapeutics Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Pet Cancer Therapeutics Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Pet Cancer Therapeutics Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Pet Cancer Therapeutics Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Pet Cancer Therapeutics Sales and Growth Rate (2015-2020)
9.3 Turkey Pet Cancer Therapeutics Sales and Growth Rate (2015-2020)
9.4 Egypt Pet Cancer Therapeutics Sales and Growth Rate (2015-2020)
9.5 South Africa Pet Cancer Therapeutics Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Pet Cancer Therapeutics Sales and Market Share by Type (2015-2020)
10.2 Global Pet Cancer Therapeutics Revenue and Market Share by Type (2015-2020)
10.3 Global Pet Cancer Therapeutics Price by Type (2015-2020)
11 Global Pet Cancer Therapeutics Market Segment by Application
11.1 Global Pet Cancer Therapeutics Sales Market Share by Application (2015-2020)
11.2 Global Pet Cancer Therapeutics Revenue Market Share by Application (2015-2020)
11.3 Global Pet Cancer Therapeutics Price by Application (2015-2020)
12 Market Forecast
12.1 Global Pet Cancer Therapeutics Sales, Revenue and Growth Rate (2021-2025)
12.2 Pet Cancer Therapeutics Market Forecast by Regions (2021-2025)
12.2.1 North America Pet Cancer Therapeutics Market Forecast (2021-2025)
12.2.2 Europe Pet Cancer Therapeutics Market Forecast (2021-2025)
12.2.3 Asia-Pacific Pet Cancer Therapeutics Market Forecast (2021-2025)
12.2.4 South America Pet Cancer Therapeutics Market Forecast (2021-2025)
12.2.5 Middle East & Africa Pet Cancer Therapeutics Market Forecast (2021-2025)
12.3 Pet Cancer Therapeutics Market Forecast by Type (2021-2025)
12.3.1 Global Pet Cancer Therapeutics Sales Forecast by Type (2021-2025)
12.3.2 Global Pet Cancer Therapeutics Market Share Forecast by Type (2021-2025)
12.4 Pet Cancer Therapeutics Market Forecast by Application (2021-2025)
12.4.1 Global Pet Cancer Therapeutics Sales Forecast by Application (2021-2025)
12.4.2 Global Pet Cancer Therapeutics Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables

Table 1. Global Pet Cancer Therapeutics Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Pet Cancer Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Pet Cancer Therapeutics Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Aratana Therapeutics, Inc Basic Information, Manufacturing Base and Competitors
Table 8. Aratana Therapeutics, Inc Pet Cancer Therapeutics Major Business
Table 9. Aratana Therapeutics, Inc Pet Cancer Therapeutics Total Revenue (USD Million) (2017-2018)
Table 10. Aratana Therapeutics, Inc SWOT Analysis
Table 11. Aratana Therapeutics, Inc Pet Cancer Therapeutics Product and Services
Table 12. Aratana Therapeutics, Inc Pet Cancer Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Rhizen Pharmaceutical SA Basic Information, Manufacturing Base and Competitors
Table 14. Rhizen Pharmaceutical SA Pet Cancer Therapeutics Major Business
Table 15. Rhizen Pharmaceutical SA Pet Cancer Therapeutics Total Revenue (USD Million) (2017-2018)
Table 16. Rhizen Pharmaceutical SA SWOT Analysis
Table 17. Rhizen Pharmaceutical SA Pet Cancer Therapeutics Product and Services
Table 18. Rhizen Pharmaceutical SA Pet Cancer Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Zenoaq Basic Information, Manufacturing Base and Competitors
Table 20. Zenoaq Pet Cancer Therapeutics Major Business
Table 21. Zenoaq Pet Cancer Therapeutics Total Revenue (USD Million) (2017-2018)
Table 22. Zenoaq SWOT Analysis
Table 23. Zenoaq Pet Cancer Therapeutics Product and Services
Table 24. Zenoaq Pet Cancer Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. AB Science Basic Information, Manufacturing Base and Competitors
Table 26. AB Science Pet Cancer Therapeutics Major Business
Table 27. AB Science Pet Cancer Therapeutics Total Revenue (USD Million) (2017-2018)
Table 28. AB Science SWOT Analysis
Table 29. AB Science Pet Cancer Therapeutics Product and Services
Table 30. AB Science Pet Cancer Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Karyopharm Therapeutics, Inc Basic Information, Manufacturing Base and Competitors
Table 32. Karyopharm Therapeutics, Inc Pet Cancer Therapeutics Major Business
Table 33. Karyopharm Therapeutics, Inc Pet Cancer Therapeutics Total Revenue (USD Million) (2017-2018)
Table 34. Karyopharm Therapeutics, Inc SWOT Analysis
Table 35. Karyopharm Therapeutics, Inc Pet Cancer Therapeutics Product and Services
Table 36. Karyopharm Therapeutics, Inc Pet Cancer Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Boehringer Ingelheim International GmbH Basic Information, Manufacturing Base and Competitors
Table 38. Boehringer Ingelheim International GmbH Pet Cancer Therapeutics Major Business
Table 39. Boehringer Ingelheim International GmbH Pet Cancer Therapeutics Total Revenue (USD Million) (2017-2018)
Table 40. Boehringer Ingelheim International GmbH SWOT Analysis
Table 41. Boehringer Ingelheim International GmbH Pet Cancer Therapeutics Product and Services
Table 42. Boehringer Ingelheim International GmbH Pet Cancer Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Oasmia Pharmaceuticals AB Basic Information, Manufacturing Base and Competitors
Table 44. Oasmia Pharmaceuticals AB Pet Cancer Therapeutics Major Business
Table 45. Oasmia Pharmaceuticals AB Pet Cancer Therapeutics Total Revenue (USD Million) (2017-2018)
Table 46. Oasmia Pharmaceuticals AB SWOT Analysis
Table 47. Oasmia Pharmaceuticals AB Pet Cancer Therapeutics Product and Services
Table 48. Oasmia Pharmaceuticals AB Pet Cancer Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. VetDC, Inc Basic Information, Manufacturing Base and Competitors
Table 50. VetDC, Inc Pet Cancer Therapeutics Major Business
Table 51. VetDC, Inc Pet Cancer Therapeutics Total Revenue (USD Million) (2017-2018)
Table 52. VetDC, Inc SWOT Analysis
Table 53. VetDC, Inc Pet Cancer Therapeutics Product and Services
Table 54. VetDC, Inc Pet Cancer Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Morphogenesis, Inc Basic Information, Manufacturing Base and Competitors
Table 56. Morphogenesis, Inc Pet Cancer Therapeutics Major Business
Table 57. Morphogenesis, Inc Pet Cancer Therapeutics Total Revenue (USD Million) (2017-2018)
Table 58. Morphogenesis, Inc SWOT Analysis
Table 59. Morphogenesis, Inc Pet Cancer Therapeutics Product and Services
Table 60. Morphogenesis, Inc Pet Cancer Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Regeneus Ltd. Basic Information, Manufacturing Base and Competitors
Table 62. Regeneus Ltd. Pet Cancer Therapeutics Major Business
Table 63. Regeneus Ltd. Pet Cancer Therapeutics Total Revenue (USD Million) (2017-2018)
Table 64. Regeneus Ltd. SWOT Analysis
Table 65. Regeneus Ltd. Pet Cancer Therapeutics Product and Services
Table 66. Regeneus Ltd. Pet Cancer Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Zoetis Basic Information, Manufacturing Base and Competitors
Table 68. Zoetis Pet Cancer Therapeutics Major Business
Table 69. Zoetis Pet Cancer Therapeutics Total Revenue (USD Million) (2017-2018)
Table 70. Zoetis SWOT Analysis
Table 71. Zoetis Pet Cancer Therapeutics Product and Services
Table 72. Zoetis Pet Cancer Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Global Pet Cancer Therapeutics Sales by Manufacturer (2018-2019) (K Units)
Table 74. Global Pet Cancer Therapeutics Revenue by Manufacturer (2018-2019) (USD Million)
Table 75. Global Pet Cancer Therapeutics Sales by Regions (2015-2020) (K Units)
Table 76. Global Pet Cancer Therapeutics Sales Market Share by Regions (2015-2020)
Table 77. Global Pet Cancer Therapeutics Revenue by Regions (2015-2020) (USD Million)
Table 78. North America Pet Cancer Therapeutics Sales by Countries (2015-2020) (K Units)
Table 79. North America Pet Cancer Therapeutics Sales Market Share by Countries (2015-2020)
Table 80. North America Pet Cancer Therapeutics Revenue by Countries (2015-2020) (USD Million)
Table 81. North America Pet Cancer Therapeutics Revenue Market Share by Countries (2015-2020)
Table 82. Europe Pet Cancer Therapeutics Sales by Countries (2015-2020) (K Units)
Table 83. Europe Pet Cancer Therapeutics Sales Market Share by Countries (2015-2020)
Table 84. Europe Pet Cancer Therapeutics Revenue by Countries (2015-2020) (USD Million)
Table 85. Asia-Pacific Pet Cancer Therapeutics Sales by Regions (2015-2020) (K Units)
Table 86. Asia-Pacific Pet Cancer Therapeutics Sales Market Share by Regions (2015-2020)
Table 87. Asia-Pacific Pet Cancer Therapeutics Revenue by Regions (2015-2020) (USD Million)
Table 88. South America Pet Cancer Therapeutics Sales by Countries (2015-2020) (K Units)
Table 89. South America Pet Cancer Therapeutics Sales Market Share by Countries (2015-2020)
Table 90. South America Pet Cancer Therapeutics Revenue by Countries (2015-2020) (USD Million)
Table 91. South America Pet Cancer Therapeutics Revenue Market Share by Countries (2015-2020)
Table 92. Middle East & Africa Pet Cancer Therapeutics Sales by Countries (2015-2020) (K Units)
Table 93. Middle East & Africa Pet Cancer Therapeutics Sales Market Share by Countries (2015-2020)
Table 94. Middle East & Africa Pet Cancer Therapeutics Revenue by Countries (2015-2020) (USD Million)
Table 95. Middle East & Africa Pet Cancer Therapeutics Revenue Market Share by Countries (2015-2020)
Table 96. Global Pet Cancer Therapeutics Sales by Type (2015-2020) (K Units)
Table 97. Global Pet Cancer Therapeutics Sales Share by Type (2015-2020)
Table 98. Global Pet Cancer Therapeutics Revenue by Type (2015-2020) (USD Million)
Table 99. Global Pet Cancer Therapeutics Revenue Share by Type (2015-2020)
Table 100. Global Pet Cancer Therapeutics Sales by Application (2015-2020) (K Units)
Table 101. Global Pet Cancer Therapeutics Sales Share by Application (2015-2020)
Table 102. Global Pet Cancer Therapeutics Sales Forecast by Regions (2021-2025) (K Units)
Table 103. Global Pet Cancer Therapeutics Market Share Forecast by Regions (2021-2025)
Table 104. Global Pet Cancer Therapeutics Sales Forecast by Type (2021-2025) (K Units)
Table 105. Global Pet Cancer Therapeutics Market Share Forecast by Type (2021-2025)
Table 106. Global Pet Cancer Therapeutics Sales Forecast by Application (2021-2025)
Table 107. Global Pet Cancer Therapeutics Market Share Forecast by Application (2021-2025)
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Pet Cancer Therapeutics Picture
Figure 2. Global Sales Market Share of Pet Cancer Therapeutics by Type in 2019
Figure 3. Chemotherapy Picture
Figure 4. Targeted Therapy Picture
Figure 5. Combination Therapy Picture
Figure 6. Immunotherapy Picture
Figure 7. Pet Cancer Therapeutics Sales Market Share by Application in 2018
Figure 8. Lymphoma Picture
Figure 9. Mast Cell Cancer Picture
Figure 10. Melanoma Picture
Figure 11. Mammary Picture
Figure 12. Squamous Cell Cancer Picture
Figure 13. Others Picture
Figure 14. Global Pet Cancer Therapeutics Market Status and Outlook (2015-2025) (USD Million)
Figure 15. United States Pet Cancer Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Canada Pet Cancer Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Mexico Pet Cancer Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Germany Pet Cancer Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 19. France Pet Cancer Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 20. UK Pet Cancer Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Russia Pet Cancer Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Italy Pet Cancer Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 23. China Pet Cancer Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Japan Pet Cancer Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Korea Pet Cancer Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 26. India Pet Cancer Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Southeast Asia Pet Cancer Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Australia Pet Cancer Therapeutics Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 29. Brazil Pet Cancer Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Egypt Pet Cancer Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Saudi Arabia Pet Cancer Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 32. South Africa Pet Cancer Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Turkey Pet Cancer Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 34. Global Pet Cancer Therapeutics Sales Market Share by Manufacturer in 2019
Figure 35. Global Pet Cancer Therapeutics Revenue Market Share by Manufacturer in 2019
Figure 36. Top 3 Pet Cancer Therapeutics Manufacturer (Revenue) Market Share in 2019
Figure 37. Top 6 Pet Cancer Therapeutics Manufacturer (Revenue) Market Share in 2019
Figure 38. Key Manufacturer Market Share Trend
Figure 39. Global Pet Cancer Therapeutics Sales and Growth Rate (2015-2020) (K Units)
Figure 40. Global Pet Cancer Therapeutics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 41. Global Pet Cancer Therapeutics Revenue Market Share by Regions (2015-2020)
Figure 42. Global Pet Cancer Therapeutics Revenue Market Share by Regions in 2018
Figure 43. North America Pet Cancer Therapeutics Sales and Growth Rate (2015-2020)
Figure 44. Europe Pet Cancer Therapeutics Sales and Growth Rate (2015-2020)
Figure 45. Asia-Pacific Pet Cancer Therapeutics Sales and Growth Rate (2015-2020)
Figure 46. South America Pet Cancer Therapeutics Sales and Growth Rate (2015-2020)
Figure 47. Middle East & Africa Pet Cancer Therapeutics Sales and Growth Rate (2015-2020)
Figure 48. North America Pet Cancer Therapeutics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 49. North America Pet Cancer Therapeutics Sales Market Share by Countries (2015-2020)
Figure 50. North America Pet Cancer Therapeutics Sales Market Share by Countries in 2018
Figure 51. North America Pet Cancer Therapeutics Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 52. North America Pet Cancer Therapeutics Revenue Market Share by Countries in 2018
Figure 53. United States Pet Cancer Therapeutics Sales and Growth Rate (2015-2020) (K Units)
Figure 54. Canada Pet Cancer Therapeutics Sales and Growth Rate (2015-2020) (K Units)
Figure 55. Mexico Pet Cancer Therapeutics Sales and Growth Rate (2015-2020) (K Units)
Figure 56. Europe Pet Cancer Therapeutics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 57. Europe Pet Cancer Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 58. Europe Pet Cancer Therapeutics Revenue Market Share by Countries in 2019
Figure 59. Germany Pet Cancer Therapeutics Sales and Growth Rate (2015-2020) (K Units)
Figure 60. UK Pet Cancer Therapeutics Sales and Growth Rate (2015-2020) (K Units)
Figure 61. France Pet Cancer Therapeutics Sales and Growth Rate (2015-2020) (K Units)
Figure 62. Russia Pet Cancer Therapeutics Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Italy Pet Cancer Therapeutics Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Asia-Pacific Pet Cancer Therapeutics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 65. Asia-Pacific Pet Cancer Therapeutics Sales Market Share by Regions 2019
Figure 66. Asia-Pacific Pet Cancer Therapeutics Revenue Market Share by Regions 2019
Figure 67. China Pet Cancer Therapeutics Sales and Growth Rate (2015-2020) (K Units)
Figure 68. Japan Pet Cancer Therapeutics Sales and Growth Rate (2015-2020) (K Units)
Figure 69. Korea Pet Cancer Therapeutics Sales and Growth Rate (2015-2020) (K Units)
Figure 70. India Pet Cancer Therapeutics Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Southeast Asia Pet Cancer Therapeutics Sales and Growth Rate (2015-2020) (K Units)
Figure 72. South America Pet Cancer Therapeutics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. South America Pet Cancer Therapeutics Sales Market Share by Countries in 2019
Figure 74. South America Pet Cancer Therapeutics Revenue Market Share by Countries in 2019
Figure 75. Brazil Pet Cancer Therapeutics Sales and Growth Rate (2015-2020) (K Units)
Figure 76. Argentina Pet Cancer Therapeutics Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Middle East and Africa Pet Cancer Therapeutics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 78. Middle East and Africa Pet Cancer Therapeutics Sales Market Share by Countries in 2019
Figure 79. Middle East and Africa Pet Cancer Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 80. Middle East and Africa Pet Cancer Therapeutics Revenue Market Share by Countries in 2019
Figure 81. Saudi Arabia Pet Cancer Therapeutics Sales and Growth Rate (2015-2020) (K Units)
Figure 82. Egypt Pet Cancer Therapeutics Sales and Growth Rate (2015-2020) (K Units)
Figure 83. Turkey Pet Cancer Therapeutics Sales and Growth Rate (2015-2020) (K Units)
Figure 84. South Africa Pet Cancer Therapeutics Sales and Growth Rate (2015-2020) (K Units)
Figure 85. Global Pet Cancer Therapeutics Sales and Growth Rate (2021-2025) (K Units)
Figure 86. Global Pet Cancer Therapeutics Revenue and Growth Rate (2021-2025) (USD Million)
Figure 87. North America Sales Pet Cancer Therapeutics Market Forecast (2021-2025) (K Units)
Figure 88. Europe Sales Pet Cancer Therapeutics Market Forecast (2021-2025) (K Units)
Figure 89. Asia-Pacific Sales Pet Cancer Therapeutics Market Forecast (2021-2025) (K Units)
Figure 90. South America Sales Pet Cancer Therapeutics Market Forecast (2021-2025) (K Units)
Figure 91. Middle East & Africa Sales Pet Cancer Therapeutics Market Forecast (2021-2025) (K Units)
Figure 92. Sales Channel: Direct Channel vs Indirect Channel



• 英文レポート名:Global Pet Cancer Therapeutics Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
• 日本語訳:ペット用がん治療の世界市場 2020年:メーカー別、地域別、種類・用途別
• レポートコード:D005-12013お問い合わせ(見積依頼・ご注文・質問)